{
  "cik": "0001789972",
  "name": "Cullinan Therapeutics, Inc.",
  "entityType": "operating",
  "sic": "2836",
  "sicDescription": "Biological Products, (No Diagnostic Substances)",
  "stateOfIncorporation": "",
  "stateOfIncorporationDescription": "",
  "fiscalYearEnd": "1231",
  "tickers": [
    "CGEM"
  ],
  "exchanges": [
    "Nasdaq"
  ],
  "ein": "813879991",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "Large accelerated filer",
  "phone": "617-410-4650",
  "flags": "",
  "formerNames": [
    {
      "name": "Cullinan Oncology, Inc.",
      "from": "2021-02-26T05:00:00.000Z",
      "to": "2024-04-02T04:00:00.000Z"
    },
    {
      "name": "Cullinan Management, Inc.",
      "from": "2020-12-01T05:00:00.000Z",
      "to": "2021-02-22T05:00:00.000Z"
    },
    {
      "name": "Cullinan Oncology, LLC",
      "from": "2020-11-02T05:00:00.000Z",
      "to": "2021-01-06T05:00:00.000Z"
    }
  ],
  "filings_count": 362,
  "download_timestamp": "2025-08-02 07:24:10 UTC"
}